Terms: = Breast cancer AND SETBP1, Q9UEF3, Q6P6C3, A6H8W5, Q9Y6X0, 26040, SEB, KIAA0437, ENSG00000152217
25 results:
1. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
2. Simultaneous
Eggert MC; Janssen S; Yu NY; Rades D
Anticancer Res; 2023 Oct; 43(10):4651-4655. PubMed ID: 37772551
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population.
Chen R; Qi Y; Huang Y; Liu W; Yang R; Zhao X; Wu Y; Li Q; Wang Z; Sun X; Wei B; Chen J
Breast Cancer Res Treat; 2023 Jan; 197(1):189-200. PubMed ID: 36346486
[TBL] [Abstract] [Full Text] [Related]
4. Application of Feature Selection and Deep Learning for cancer Prediction Using DNA Methylation Markers.
Gomes R; Paul N; He N; Huber AF; Jansen RJ
Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140725
[TBL] [Abstract] [Full Text] [Related]
5. Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer.
Uddin MN; Wang X
Breast Cancer; 2022 May; 29(3):541-561. PubMed ID: 35020130
[TBL] [Abstract] [Full Text] [Related]
6. A comparative study on hypofractionated whole-breast irradiation with sequential or simultaneous integrated boost on different positions after breast-conserving surgery.
Yu T; Li Y; Sun T; Xu M; Wang W; Shao Q; Zhang Y; Li J; Yu J
Sci Rep; 2021 Sep; 11(1):18017. PubMed ID: 34504253
[TBL] [Abstract] [Full Text] [Related]
7. Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: Comparison with sequential boost in a randomized trial.
Van Hulle H; Desaunois E; Vakaet V; Paelinck L; Schoepen M; Post G; Van Greveling A; Speleers B; Mareel M; De Neve W; Monten C; Deseyne P; Veldeman L
Radiother Oncol; 2021 May; 158():62-66. PubMed ID: 33617910
[TBL] [Abstract] [Full Text] [Related]
8. Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions.
Costantini L; Magno S; Albanese D; Donati C; Molinari R; Filippone A; Masetti R; Merendino N
Sci Rep; 2018 Nov; 8(1):16893. PubMed ID: 30442969
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting setbp1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract] [Full Text] [Related]
10. Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial.
Paelinck L; Gulyban A; Lakosi F; Vercauteren T; De Gersem W; Speleers B; Monten C; Mulliez T; Berkovic P; van Greveling A; Decoster F; Coucke P; De Neve W; Veldeman L
Radiother Oncol; 2017 Jan; 122(1):30-36. PubMed ID: 28062087
[TBL] [Abstract] [Full Text] [Related]
11. Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal breast cancers is Unaffected by Biopsy Volume.
Focke CM; Decker T; van Diest PJ
Ann Surg Oncol; 2017 May; 24(5):1251-1257. PubMed ID: 28008571
[TBL] [Abstract] [Full Text] [Related]
12. Tagging staphylococcal enterotoxin B (seb) with TGFaL3 for breast cancer therapy.
Yousefi F; Siadat SD; Saraji AA; Hesaraki S; Aslani MM; Mousavi SF; Imani Fooladi AA
Tumour Biol; 2016 Apr; 37(4):5305-16. PubMed ID: 26561468
[TBL] [Abstract] [Full Text] [Related]
13. Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy.
Imani Fooladi AA; Halabian R; Mahdavi M; Amin M; Mahmoodzadeh Hosseini H
Tumour Biol; 2016 Jan; 37(1):739-48. PubMed ID: 26245994
[TBL] [Abstract] [Full Text] [Related]
14. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Michailidou K; Beesley J; Lindstrom S; Canisius S; Dennis J; Lush MJ; Maranian MJ; Bolla MK; Wang Q; Shah M; Perkins BJ; Czene K; Eriksson M; Darabi H; Brand JS; Bojesen SE; Nordestgaard BG; Flyger H; Nielsen SF; Rahman N; Turnbull C; ; Fletcher O; Peto J; Gibson L; dos-Santos-Silva I; Chang-Claude J; Flesch-Janys D; Rudolph A; Eilber U; Behrens S; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Khan S; Aaltonen K; Ahsan H; Kibriya MG; Whittemore AS; John EM; Malone KE; Gammon MD; Santella RM; Ursin G; Makalic E; Schmidt DF; Casey G; Hunter DJ; Gapstur SM; Gaudet MM; Diver WR; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Berg CD; Chanock SJ; Figueroa J; Hoover RN; Lambrechts D; Neven P; Wildiers H; van Limbergen E; Schmidt MK; Broeks A; Verhoef S; Cornelissen S; Couch FJ; Olson JE; Hallberg E; Vachon C; Waisfisz Q; Meijers-Heijboer H; Adank MA; van der Luijt RB; Li J; Liu J; Humphreys K; Kang D; Choi JY; Park SK; Yoo KY; Matsuo K; Ito H; Iwata H; Tajima K; Guénel P; Truong T; Mulot C; Sanchez M; Burwinkel B; Marme F; Surowy H; Sohn C; Wu AH; Tseng CC; Van Den Berg D; Stram DO; González-Neira A; Benitez J; Zamora MP; Perez JI; Shu XO; Lu W; Gao YT; Cai H; Cox A; Cross SS; Reed MW; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; ; ; Lindblom A; Margolin S; Teo SH; Yip CH; Taib NA; Tan GH; Hooning MJ; Hollestelle A; Martens JW; Collée JM; Blot W; Signorello LB; Cai Q; Hopper JL; Southey MC; Tsimiklis H; Apicella C; Shen CY; Hsiung CN; Wu PE; Hou MF; Kristensen VN; Nord S; Alnaes GI; ; Giles GG; Milne RL; McLean C; Canzian F; Trichopoulos D; Peeters P; Lund E; Sund M; Khaw KT; Gunter MJ; Palli D; Mortensen LM; Dossus L; Huerta JM; Meindl A; Schmutzler RK; Sutter C; Yang R; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Hartman M; Miao H; Chia KS; Chan CW; Fasching PA; Hein A; Beckmann MW; Haeberle L; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Ashworth A; Orr N; Schoemaker MJ; Swerdlow AJ; Brinton L; Garcia-Closas M; Zheng W; Halverson SL; Shrubsole M; Long J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Brauch H; Hamann U; Brüning T; ; Radice P; Peterlongo P; Manoukian S; Bernard L; Bogdanova NV; Dörk T; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; Jakubowska A; Lubinski J; Jaworska K; Huzarski T; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Slager S; Toland AE; Ambrosone CB; Yannoukakos D; Kabisch M; Torres D; Neuhausen SL; Anton-Culver H; Luccarini C; Baynes C; Ahmed S; Healey CS; Tessier DC; Vincent D; Bacot F; Pita G; Alonso MR; Álvarez N; Herrero D; Simard J; Pharoah PP; Kraft P; Dunning AM; Chenevix-Trench G; Hall P; Easton DF
Nat Genet; 2015 Apr; 47(4):373-80. PubMed ID: 25751625
[TBL] [Abstract] [Full Text] [Related]
15. Staphylococcal entorotoxin B anchored exosome induces apoptosis in negative esterogen receptor breast cancer cells.
Mahmoodzadeh Hosseini H; Imani Fooladi AA; Soleimanirad J; Nourani MR; Davaran S; Mahdavi M
Tumour Biol; 2014 Apr; 35(4):3699-707. PubMed ID: 24399649
[TBL] [Abstract] [Full Text] [Related]
16. A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.
Hein R; Flesch-Janys D; Dahmen N; Beckmann L; Lindström S; Schoof N; Czene K; Mittelstraß K; Illig T; Seibold P; Behrens S; Humphreys K; Li J; Liu J; Olson JE; Wang X; Hankinson SE; Truong T; Menegaux F; Dos Santos Silva I; Johnson N; ; Chen ST; Yu JC; Ziogas A; Kataja V; Kosma VM; Mannermaa A; Anton-Culver H; Shen CY; Brauch H; Peto J; Guénel P; Kraft P; Couch FJ; Easton DF; Hall P; Chang-Claude J
Breast Cancer Res Treat; 2013 Apr; 138(2):529-542. PubMed ID: 23423446
[TBL] [Abstract] [Full Text] [Related]
17. Latent class modelling of the association between socioeconomic background and breast cancer survival status at 5 years incorporating stage of disease.
Downing A; Harrison WJ; West RM; Forman D; Gilthorpe MS
J Epidemiol Community Health; 2010 Sep; 64(9):772-6. PubMed ID: 19692736
[TBL] [Abstract] [Full Text] [Related]
18. Socioeconomic background in relation to stage at diagnosis, treatment and survival in women with breast cancer.
Downing A; Prakash K; Gilthorpe MS; Mikeljevic JS; Forman D
Br J Cancer; 2007 Mar; 96(5):836-40. PubMed ID: 17311024
[TBL] [Abstract] [Full Text] [Related]
19. A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia.
Stearns V; Coop A; Singh B; Gallagher A; Yamauchi H; Lieberman R; Pennanen M; Trock B; Hayes DF; Ellis MJ
Clin Cancer Res; 2004 Nov; 10(22):7583-91. PubMed ID: 15569989
[TBL] [Abstract] [Full Text] [Related]
20. Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.
Singletary SE; Atkinson EN; Hoque A; Sneige N; Sahin AA; Fritsche HA; Lotan R; Lu T; Hittelman WN; Bevers TB; Stelling CB; Lippman SM
Clin Cancer Res; 2002 Sep; 8(9):2835-42. PubMed ID: 12231524
[TBL] [Abstract] [Full Text] [Related]
[Next]
